Verwiel Frank

CIK 00015457944 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001545794

Recent Transactions

48 trades

Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2026-06-09+13,300→ 13,300 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-06-09+9,200→ 35,148 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-06-11+11,450→ 11,450 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-06-11+8,000→ 25,948 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-06-17$25.00/sh−1,505→ 17,948 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-06-12+7,737→ 19,453 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-06-12+11,515→ 11,515 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-06-14+6,473→ 6,473 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-06-14+4,425→ 11,716 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-06-14+7,688→ 7,688 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-06-14+5,197→ 7,291 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-06-23+2,094→ 2,094 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-06-23+3,382→ 3,382 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2020-06-18+19,000→ 19,000 total
Disposition to Issuer
ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
2020-01-28−42,000→ 0 total
Disposition to Issuer
ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
2020-01-28−30,000→ 0 total
Disposition to Issuer
ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
2020-01-28−30,000→ 0 total
Disposition to Issuer
ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
2020-01-28−30,000→ 0 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2019-05-21+19,000→ 19,000 total
Award
ACHILLION PHARMACEUTICALS INC
Stock Option (Right to buy)
2019-01-23+42,000→ 42,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2018-05-17+19,000→ 19,000 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−2,905→ 0 total
Disposition to Issuer
AveXis, Inc.
Common Stock
2018-05-15−1,106→ 0 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−26,496→ 0 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−2,454→ 0 total
Award
AveXis, Inc.
Common Stock
2018-03-13+1,106→ 1,106 total
Award
AveXis, Inc.
Stock Option (Right to Buy)
2018-03-13+2,905→ 2,905 total
Award
ACHILLION PHARMACEUTICALS INC
Employee Stock Option
2018-02-09+30,000→ 30,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2017-07-25+38,000→ 38,000 total
Award
AveXis, Inc.
Stock Option (Right to Buy)
2017-05-30+2,454→ 2,454 total
Award
ACHILLION PHARMACEUTICALS INC
Employee Stock Option
2017-01-19+30,000→ 30,000 total
Award
AveXis, Inc.
Stock Option (Right to Buy)
2016-02-10+8,385→ 8,385 total
Award
AveXis, Inc.
Stock Option (Right to Buy)
2016-02-10+18,111→ 18,111 total
Award
ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
2016-01-25+30,000→ 30,000 total
Award
ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
2015-12-14+30,000→ 30,000 total
Disposition to Issuer
INTERMUNE INC
Stock options (right to buy)
2014-09-29−6,000→ 0 total
Disposition to Issuer
INTERMUNE INC
Stock options (right to buy)
2014-09-29−8,000→ 0 total
Disposition to Issuer
INTERMUNE INC
Restricted stock units
2014-09-29−4,000→ 0 total
Disposition to Issuer
INTERMUNE INC
Common stock
2014-09-29$74.00/sh−9,725→ 0 total
Disposition to Issuer
INTERMUNE INC
Stock options (right to buy)
2014-09-29−10,500→ 0 total
Award
INTERMUNE INC
Restricted Stock Units
2013-05-30+3,000→ 3,000 total
Award
INTERMUNE INC
Stock Option (Right to Buy)
2013-05-30+6,000→ 6,000 total
Award
INTERMUNE INC
Stock Option (Right to Buy)
2012-06-04+6,000→ 6,000 total
Award
INTERMUNE INC
Common Stock
2012-06-04$10.10/sh+2,500→ 6,725 total
Award
INTERMUNE INC
Common Stock
2012-04-06+625→ 4,225 total
Award
INTERMUNE INC
Common Stock
2012-04-06+3,600→ 3,600 total
Award
INTERMUNE INC
Stock Option (Right to Buy)
2012-04-06+9,000→ 9,000 total
Award
INTERMUNE INC
Stock Option (Right to Buy)
2012-04-06+1,500→ 1,500 total

Companies

Recent Filings

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139

View on SEC.gov